APC and liver cancer: The APC promoter was reported to be hypermethylated in about 64.91 to 84% liver cancer patients (listed in Table 1), which was significantly higher than the non-HCC group (58–62), and a strong association was detected between hypermethylation and the risk of suffering from HCC (71).